NB medication (Naltrexone Bupropion combination): Clinical Trials

2 trials of NB medication (Naltrexone Bupropion combination), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 32Completed 2

Follow NB medication (Naltrexone Bupropion combination): new trials by email Literature Review of NB medication (Naltrexone Bupropion combination) trials Research Report on NB medication (Naltrexone Bupropion combination)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Maintenance Therapy
NB medication (Naltrexone Bupropion combination), Placebo - Binge-Eating Disorder, Obesity
Phase 2 / Phase 3CompletedYale University682017-08-282024-02-02
Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Acute Treatment
NB medication (Naltrexone Bupropion combination), Behavioral Weight Loss (BWL) counseling, Placebo - Binge-eating Disorder, Obesity
Phase 2 / Phase 3CompletedYale University1362017-02-272023-03-08

Conditions studied

Binge-Eating Disorder (2)  ·  Obesity (2)

Sponsors

Yale University (2)

Countries

United States (2)

Top investigators

Carlos Grilo, PhD (1)  ·  Carlos M Grilo, PhD (1)

Results publications

PMID 36285406

NIH funding

R01DK049587 (2)